201 related articles for article (PubMed ID: 15962527)
1. Pemetrexed disodium.
Gibbs D; Jackman A
Nat Rev Drug Discov; 2005 May; Suppl():S16-7. PubMed ID: 15962527
[TBL] [Abstract][Full Text] [Related]
2. Pemetrexed and its emerging role in the treatment of thoracic malignancies.
Scagliotti GV; Novello S
Expert Opin Investig Drugs; 2003 May; 12(5):853-63. PubMed ID: 12720495
[TBL] [Abstract][Full Text] [Related]
3. The role of pemetrexed in lung cancer.
Wang D; He J
Curr Drug Targets; 2010 Jan; 11(1):1. PubMed ID: 20017724
[No Abstract] [Full Text] [Related]
4. Pemetrexed disodium for the treatment of NSCLC: an update.
Hsu JY; Wakelee H
Drugs Today (Barc); 2008 Sep; 44(9):669-78. PubMed ID: 19137122
[TBL] [Abstract][Full Text] [Related]
5. Pemetrexed (Alimta, MTA, multitargeted antifolate, LY231514) for malignant pleural mesothelioma.
Manegold C
Semin Oncol; 2003 Aug; 30(4 Suppl 10):32-6. PubMed ID: 12917819
[TBL] [Abstract][Full Text] [Related]
6. Pemetrexed: a multitargeted antifolate.
Rollins KD; Lindley C
Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed in malignant pleural mesothelioma.
Gatzemeier U
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):26-31. PubMed ID: 15655933
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of pemetrexed (Alimta) and gemcitabine in non-small cell lung cancer.
Le Chevalier T
Semin Oncol; 2003 Aug; 30(4 Suppl 10):37-44. PubMed ID: 12947960
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed for diffuse malignant pleural mesothelioma.
Manegold C; Aisner J
Semin Oncol; 2002 Apr; 29(2 Suppl 5):30-5. PubMed ID: 12023790
[TBL] [Abstract][Full Text] [Related]
12. ALIMTA (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer.
Novello S; le Chevalier T
Lung Cancer; 2001 Dec; 34 Suppl 4():S107-9. PubMed ID: 11742713
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed disodium, a novel antifolate with multiple targets.
Curtin NJ; Hughes AN
Lancet Oncol; 2001 May; 2(5):298-306. PubMed ID: 11905785
[TBL] [Abstract][Full Text] [Related]
14. TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.
Uramoto H; Onitsuka T; Shimokawa H; Hanagiri T
Anticancer Res; 2010 Oct; 30(10):4309-15. PubMed ID: 21036757
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.
Miller KD; Picus J; Blanke C; John W; Clark J; Shulman LN; Thornton D; Rowinsky E; Loehrer PJ
Ann Oncol; 2000 Jan; 11(1):101-3. PubMed ID: 10690396
[TBL] [Abstract][Full Text] [Related]
16. FDA drug approval summaries: pemetrexed (Alimta).
Hazarika M; White RM; Johnson JR; Pazdur R
Oncologist; 2004; 9(5):482-8. PubMed ID: 15477632
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed: a new cytotoxic agent in the development for first-line non-small-cell lung cancer.
Scagliotti GV
Lung Cancer; 2005 Oct; 50 Suppl 1():S18-9. PubMed ID: 16291426
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed (Alimta): improving outcomes in malignant pleural mesothelioma.
Budde LS; Hanna NH
Expert Rev Anticancer Ther; 2004 Jun; 4(3):361-8. PubMed ID: 15161435
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of pemetrexed (Alimta) into the treatment of non-small cell lung cancer (thoracic tumors).
Bunn PA
Semin Oncol; 2002 Jun; 29(3 Suppl 9):17-22. PubMed ID: 12094334
[TBL] [Abstract][Full Text] [Related]
20. The role of pemetrexed in second-line chemotherapy for advanced non-small cell lung cancer.
Tucker S
Curr Drug Targets; 2010 Jan; 11(1):58-60. PubMed ID: 19839927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
